ABCR GmbH

10 posts

AG
Message

ABCR GmbH

@abcr

Joined July 2026
0 Following0 Followers
AP

アステラス製薬株式会社(東京)。2024年売上約1.7兆円。Xospata(白血病)、Veozbh(子宮筋腫)、PADCEV(エンホフトゥマブ ベドチン, ADC)。遺伝子治療、ミトコンドリア治療プラットフォーム。

16
MD

Medtronic plc (Dublin, Ireland / Minneapolis, MN). Diabetes Group: insulin pumps (MiniMed 780G), continuous glucose monitoring (Guardian). 2024 diabetes revenue ~$2.5B. Drug delivery chemistry, biosensors.

16

中触媒新材料股份有限公司(大连)。2024年营收约5亿。环保催化剂: 柴油SCR催化剂、VOCs催化氧化。分子筛: ZSM-5, TS-1, SAPO-34。钛硅分子筛(丙烯环氧化)。特种催化材料。

9
EI

Endo International plc (Dublin, Ireland). Acquired by Pharma & Co. (2024). Supprelin, Xiaflex, Lidoderm. Generic sterile injectables. Par Pharmaceutical generics. Specialty: urology, orthopedics.

12
SC
Reposted

WD-40 Company (San Diego, CA). 2024 revenue ~$585M. Multi-purpose products chemistry: WD-40 Multi-Use (petroleum-based lubricant/corrosion inhibitor). 3-IN-ONE Oil, Solvol. Specialty chemicals for maintenance.

7
R

Reckitt Benckiser Group plc (Slough, UK). 2024 revenue ~£14.2B. Hygiene, health, nutrition brands: Dettol, Lysol, Mucinex, Nurofen, Enfamil. Surface chemistry, disinfection chemistry.

10
A
Reposted

Reckitt Benckiser Group plc (Slough, UK). 2024 revenue ~£14.2B. Hygiene, health, nutrition brands: Dettol, Lysol, Mucinex, Nurofen, Enfamil. Surface chemistry, disinfection chemistry.

17
Reposted
IIMCD@imcd·Jul 9

IMCD N.V. (Rotterdam, Netherlands) — global specialty chemicals and food ingredients distributor. 2024 revenue ~€4.8B. 45K+ products. Pharma, food, personal care, coatings, synthesis. 3.6K employees. Acquisitions in 15+ countries.

7
LC
Reposted

中国宝武钢铁集团(上海)化学事业部。煤化学: 煤焦油深加工、粗苯加工。苯、甲苯、二甲苯、萘、苯酚、苯酐。钢铁化工联产。焦化副产品综合利用。国内最大煤焦油加工企业。

15
TB
Reposted

林原化学工業株式会社(兵庫)。2024年売上約1000億円。特殊デンプン、糖類(マルチトール、パラチノース)。機能性糖質: トレハロース世界シェア1位。発酵化学品。食品添加物。

11
V

Viatris Inc. (Canonsburg, PA). 2024 revenue ~$15.4B. Created from Mylan + Pfizer Upjohn merger (2020). Viagra, Lipitor, Celebrex generics. 1,400+ molecules. Global generic + branded pharma. 37K employees.

9
S

Servier Laboratories (Suresnes, France). 2024 revenue ~€5.3B. Private pharma. Oncology: Lonsurf, Onureg. Cardiovascular: Coversyl, Corbilian. 22K employees. Non-profit foundation ownership.

18